OneDigital Investment Advisors LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 6,351 shares of the financial services provider’s stock, valued at approximately $537,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Plato Investment Management Ltd bought a new stake in MetLife in the second quarter valued at approximately $2,087,000. Bell Investment Advisors Inc bought a new position in shares of MetLife during the 2nd quarter worth approximately $41,000. AMG National Trust Bank acquired a new position in shares of MetLife during the 2nd quarter worth approximately $233,000. Simplicity Wealth LLC bought a new stake in MetLife in the 2nd quarter valued at $788,000. Finally, Trivium Point Advisory LLC acquired a new stake in MetLife during the 2nd quarter valued at $1,003,000. Institutional investors own 94.99% of the company’s stock.
MetLife Stock Up 0.2%
MET opened at $96.83 on Wednesday. MetLife, Inc. has a fifty-two week low of $67.33 and a fifty-two week high of $100.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The company has a market capitalization of $62.31 billion, a P/E ratio of 18.55, a P/E/G ratio of 0.75 and a beta of 0.78. The stock has a fifty day moving average of $92.00 and a 200-day moving average of $81.86.
MetLife Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s dividend payout ratio is presently 45.40%.
MetLife announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to purchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its stock is undervalued.
Analyst Ratings Changes
A number of research firms have commented on MET. TD Cowen upped their price objective on shares of MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Mizuho raised their target price on shares of MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Barclays lifted their target price on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. UBS Group increased their price target on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Finally, Piper Sandler raised their price objective on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $101.07.
View Our Latest Research Report on MET
Key Stories Impacting MetLife
Here are the key news stories impacting MetLife this week:
- Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
- Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
- Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
- Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO
About MetLife
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Featured Stories
- Five stocks we like better than MetLife
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
